俄罗斯老妇禽交rd|九九99精品视频在线观看|97色mm五月天亚洲|黄色网站a片免费中国

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

聯系電話：0851-33411018（行政部） 0851-88173360（銷售部）股票代碼：SZ 002424

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":550,"picHeight":381,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

貴州百靈企業集團制藥股份有限公司

股票代碼：SZ 002424

查看更多最新公告>

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

走進百靈

專精于藥 · 專注于人

貴州百靈企業集團制藥股份有限公司（以下簡稱“貴州百靈”）是一家從事苗藥研發、生產、銷售于一體的醫藥上市公司，注冊資本14.112億元，總資產70.59億元，員工6124人。2010年6月，公司在深圳證券交易所成功上市（股票代碼：SZ 002424）。公司明確圍繞“強化公司在苗藥領域的優勢地位，力爭成為中成藥領域具有核心競爭優勢的企業”為戰略發展目標，以實施“科技苗藥、文化苗藥、生態苗藥”為抓手，致力打造擁有大健康全產業鏈的企業集團。

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"藥材基地","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"藥材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}

致力于推動苗藥品種的科研創新

實現傳統苗藥現代化、科技化

持續挖掘和探索苗藥寶庫，以傳承

和發揚民族醫藥文化為企業使命

布局中藥材種植產業，加強道地

藥材保護，助力產業化精準扶貧

科技苗藥

文化苗藥

生態苗藥

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

產品與服務

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

非處方藥
處方藥
大健康產品

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

百靈動態

關注百靈了解更多最新資訊

百靈新聞
媒體聚焦

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":264,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492375","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/956068561682543.jpeg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=950846292492375","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492375","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492378","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/956068561682553.jpeg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=950846292492378","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=950846292492378","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":278,"cheight":162,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865548","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/956068570071050.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654853865548","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865548","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":164,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865544","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570022.jpg","picWidth":"260","picHeight":"150","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654853865544","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865544","jsonData":{}}}

貴州百靈向畢節市大方方艙醫院捐贈24000瓶“咳速停糖漿”

共抗疫情，風雨同舟——貴州百靈捐贈價值280萬元“咳速停糖漿”馳援西藏

奮楫爭先顯風采競聘就崗選英才——貴州百靈銷售部首次公開競聘活動順利舉辦

貴州百靈參股公司賾靈生物“注射用甲磺酸普依司他”治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"20","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":22,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":21,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"21","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2022-09-23

2022-09-22

2022-09-07

2022-09-02

9月2日，貴州百靈企業集團總部，隨著最后一項現場PK環節的終場哨響起，貴州百靈銷售部為期半個月的管理人員公開競聘活動正式落下帷幕。8月19日以來，根據集團戰略發展要求，為有效推動人才梯隊建設，保障并促進整體經營戰略目標的實現…詳細>

8月31日晚間，貴州百靈發布參股子公司在研項目進展公告，賾靈生物近日收到《四川大學華西醫院臨床試驗倫理審查委員會批件》，同意公司開展“注射用甲磺酸普依司他”治療復發或難治彌漫大B細胞淋巴瘤（R/R DLBCL）的有效性和安全性的開放性、多中心Ⅱ期臨床研究…詳細>

為進一步支援西藏地區疫情防控工作，攜手同心，共克時艱，9月6日以來，貴州百靈企業集團千里馳援，向西藏拉薩市、日喀則市等疫情較為嚴重的地區分批捐贈防疫藥品“咳速停糖漿”3200件…詳細>

為積極支援貴州省內疫情防控工作，同心抗疫，共度時艱，9月22日，貴州百靈企業集團向安順市紅十字會捐贈防疫藥品24000瓶“咳速停糖漿”（價值約47.5萬元），定向用于畢節市大方方艙醫院的臨床救治和疫情防控一線…詳細>

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865590","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570033.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654853865590","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654853865590","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":280,"cheight":180,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088361","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399055409194.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654837088361","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088361","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":200,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399231570022.jpg","picWidth":"280","picHeight":"180","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","linkUrl":"中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進入Ⅱ期臨床","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":268,"cheight":163,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088275","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/939399038632043.jpg","picWidth":"300","picHeight":"366","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.floristindover.com/displaynews.html?newsId=944654837088275","linkUrl":"http://www.floristindover.com/displaynews.html?newsId=944654837088275","jsonData":{}}}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2022-09-23

2022-09-15

2022-09-03

2022-08-29

為進一步支援西藏地區疫情防控工作，9月6日以來，貴州百靈企業集團千里馳援，向西藏拉薩市、日喀則市等疫情較為嚴重的地區分批捐贈防疫藥品…詳細>

連日來，位于安順經開區的貴州百靈集團，在抓深走實疫情防控的同時，生產機器“火力全開”，努力做好市場需求保障。掃碼、消毒、換工作服裝…詳細>

貴州百靈近日公告稱，公司參股子公司成都賾靈生物醫藥科技有限公司（簡稱“賾靈生物”）于近日收到《四川大學華西醫院臨床試驗倫理審查委員會批件》，同意…詳細>

8月27日，貴州百靈發布2022年半年報。報告期內，公司實現營業收入12.83億元，較上年同期增長0.74%；歸屬上市公司股東凈利潤8343萬元，較上年同期增長…詳細>

證券日報 | 貴州百靈向西藏捐贈價值280萬元“咳速停糖漿”

貴州日報天眼新聞 | 貴州百靈集團：疫情防控不放松，企業生產不誤時

中國證券報 | 貴州百靈：甲磺酸普依司他治療復發或難治彌漫大B淋巴瘤進…

上海證券報 | 貴州百靈上半年業績逆勢小幅增長糖寧通絡國家課題等獲重大進展

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

投資者關系

與您共享貴州百靈的發展和成績

關注我們

掃一掃關注公眾號

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":96,"cheight":98,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889260.png","picWidth":100,"picHeight":98,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":1220,"cheight":39,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889261.webp","picWidth":1220,"picHeight":39,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

聯系我們

聯系電話：

0851-33411018（行政部）

0851-88173360（銷售部）　

地址：貴州省安順市經濟技術

開發區西航大道　

傳真：0851-33411559

走進百靈

產品與服務

新聞中心

投資者關系

職業發展

責任與公益